載入...
Ceftriaxone (Ro 13-9904) therapy of serious infection.
Ceftriaxone (Ro 13-9904), a newly developed cephalosporin with a long half-life, was evaluated for efficacy and safety in 19 patients with serious infections. Underlying illnesses were present in 16 patients. Ceftriaxone was given intravenously every 12 h. Infections treated included gram-negative b...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
1982
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC183670/ https://ncbi.nlm.nih.gov/pubmed/6289739 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|